Delivery Order SPE2DB20D3101-SPE2DB24FRTZ8
Award Date
9/5/24
Potential Completion Date
9/6/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,583.28 firm fixed-price delivery order is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a medical product used in healthcare settings. The contract has an ultimate completion date of May 23, 2024 and is not designated as a set-aside award. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply CEFAZOLIN 1 G/50 ML-DEXTROSES. The $2,904.77 firm fixed-price delivery order has a completion date of July 23, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,307.25 firm-fixed-price delivery order is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product, with a period of performance through October 30, 2024. The award is not designated as a set-aside contract. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,212.28 Firm Fixed Price Delivery Order contract is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a medical product used in healthcare settings. The contract has an ultimate completion date of January 16, 2025 and was awarded on January 15, 2025. It is not designated as a set-aside contract....
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the supply of 4,563,557,556 units of the pharmaceutical product CEFAZOLIN 2 G/50 ML-DEXTROSES. The potential value of the contract is $1,469.52 and the period of performance runs through February 6, 2024. This contract does not have a set-aside...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the provision of CEFAZOLIN 2 G/50 ML-DEXTROSES medical supplies. The contract has an award value of $1,032.45 and a completion date of July 29, 2024. It is a delivery order contract under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $1,532.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product. The contract is not designated as a set-aside and has an ultimate completion date of January 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,228.56 firm fixed-price delivery order is for the supply of 4567644031 CEFAZOLIN 2 G/50 ML-DEXTROSES, a medical product. The contract has an ultimate completion date of March 21, 2025 and was awarded on March 20, 2025. It is not associated with a set-aside program. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,167.92 firm fixed-price delivery order provides for the supply of 4566150201 - CEFAZOLIN 2 G/50 ML-DEXTROSES, a medical product for military healthcare programs. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The federal contract award is for the delivery of CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,047.60 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 1, 2025, with a performance period through April 2, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...